• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR Back to Search Results
Model Number CNWTT0
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Visual Disturbances (2140); Prolapse (2475)
Date of Event 07/23/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A product was not returned for analysis.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A health care professional after surgery reported that patient experienced severe halos in the left eye which are causing her to be homebound because she cannot drive.The iol (intraocular lens) was explanted and exchanged for an unknown lens in the secondary implant procedure.Additional information have been received and it states that there was no impact to the patient.Additional information have been received and it states that the patient was experienced extreme halo's that she could not tolerate and lens was exchanged in the left eye.Patient returned for a post operation visit and had a corneal filament removed.Vision has increased by approx.50 percent since exchange.Patient came in on next month observed that vision was better.Patient was referred to a retinal specialist to verify position of the iol.She was seen by retina.Patient was found to have a vitreous prolapse, iol in good position.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS
Common Device Name
LENS, MULTIFOCAL INTRAOCULAR
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key21881363
Report Number9612169-2025-00657
Device Sequence Number18093623
Product Code MFK
UDI-Device Identifier00380652408080
UDI-Public(01)00380652408080(17)280127(11)240129(10)25773333
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2025
Reporter Type Manufacturer
Report Source Study,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 04/22/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberCNWTT0
Device Catalogue NumberCNWTT0.180
Device Lot Number25773333
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/25/2025
Initial Report FDA Received Date04/22/2025
Date Device Manufactured01/29/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ACRYSOF MULTIPIECE IOL; DUOVISC; MCPHERSON FORCEPS; MONARCH III CARTRIDGE D; MONARCH III INJECTOR
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient SexFemale
-
-